Patents by Inventor Inder P. S. Grover

Inder P. S. Grover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4997959
    Abstract: A process for the hydrogenation of a 6-methylenetetracycline in the production of alpha-6-deoxytetracycline, particularly the antibiotic doxycycline, in the presence of a transition metal complex of the formula MCl.sub.x (PPh.sub.3).sub.y wherein M is Cu, Co or Ni, x is 1 or 2 and y is 1-3, and a trace of rhodium either as the supported metal or as a rhodium salt, as a hydrogenation catalyst. The desired alpha-6-deoxytetracycline product is produced in high yields and stereospecificities. The process requires the use of substantially cheaper transition metal complexes and only traces of rhodium in the hydrogenation catalyst per mole of the 6-methylene tetracycline hydrogenated.
    Type: Grant
    Filed: April 13, 1989
    Date of Patent: March 5, 1991
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagmohan Khanna, Kiran Bala, Inder P. S. Grover
  • Patent number: 4990636
    Abstract: A coordination compound useful as a hydrogenation catalyst, having the formula: ##STR1## wherein Ph is phenyl; R is hydrogen or C.sub.1 -C.sub.4 alkyl; and X is chloro, bromo or iodo. This compound is particularly useful as a homogeneous hydrogenation catalyst in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
    Type: Grant
    Filed: February 9, 1990
    Date of Patent: February 5, 1991
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagmohan Khanna, Kiran Bala, Inder P. S. Grover
  • Patent number: 4987242
    Abstract: A coordination compound useful as a hydrogenation catalyst, having the formula: ##STR1## wherein Ph is phenyl; R is hydrogen or C.sub.1 -C.sub.4 alkyl; and X is chloro, bromo or iodo. This compound is particularly useful as a homogeneous hydrogenation catalyst in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
    Type: Grant
    Filed: November 29, 1989
    Date of Patent: January 22, 1991
    Inventors: Jagmohan Khanna, Kiran Bala, Inder P. S. Grover
  • Patent number: 4973719
    Abstract: A process for the hydrogenation of a 6-methylenetetracycline in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline, in the presence of hydriodotetrakis (triphenylphosphine) rhodium (I) as a homogenous hydrogenation catalyst. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: November 27, 1990
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagmohan Khanna, Kiran Bala, Inder P. S. Grover
  • Patent number: 4902447
    Abstract: A coordination compound useful as a hydrogenation catalyst, having the formula: ##STR1## wherein Ph is phenyl; R is hydrogen or C.sub.1 -C.sub.4 alkyl; and X is chloro, bromo or iodo. This compound is particularly useful as a homogeneous hydrogenation catalyst in the production of alpha-6-deoxytetracyclines, particularly the antibiotic doxycycline. The desired alpha-6-deoxy product is produced in high yields and stereospecificities, the process requiring the use of minimal quantities of rhodium metal in the hydrogenation catalyst per mole of the 6-methylenetetracycline hydrogenated.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: February 20, 1990
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagmohan Khanna, Kiran Bala, Inder P. S. Grover